PharmaLex Denmark A/S: Financial statements 2020
CVR: 18652439
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
PharmaLex Denmark A/S (CVR 18652439) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 21,537,258 and a net result of DKK 4,266,469 compared with DKK 3,695,302 the year before. That is an increase of 26.4% compared with the year before. Equity in the 2020 report amounted to DKK 6,219,290. The solvency ratio was 43.4%. The company had 23 employees in the financial year.
- Gross Profit
- DKK 21,537,258
- Profit/Loss
- DKK 4,266,469
- Equity
- DKK 6,219,290
- Total Assets
- DKK 14,318,372
- Employees
- 23
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 21.5 mio. | 4.3 mio. | 6.2 mio. | 23 |
| 2019 | - | 17 mio. | 3.7 mio. | 6 mio. | 18 |
| 2018 | - | 13.4 mio. | 2.9 mio. | 4.1 mio. | 15 |
| 2017 | - | 14.5 mio. | -1.6 mio. | 1.2 mio. | 21 |
| 2016 | - | 22.4 mio. | 5.3 mio. | 6.6 mio. | 30 |
Official annual report
How creditworthy is PharmaLex Denmark A/S?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
PharmaLex Denmark A/S has published its annual report for 2019. Gross profit came to DKK 17,037,411, and the net result was DKK 3,695,302.
About PharmaLex Denmark A/S
PharmaLex Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 1995. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named JACOBSEN PHARMA CONSULTANCY A/S and SLP NR. 11.026 A/S. The management consists of Åsa Pihlblad. The board consists of Christopher Gauglitz (chair), Carlos Antonio Santaflorentina Juanino and Åsa Pihlblad. The company is owned by Pharmalex Nordic ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 17,235,093 and a net result of DKK -1,712,095 compared with DKK 1,745,746 the year before. Equity in the 2025 report amounted to DKK 2,761,242.